Metaphylaxis of nephrolithiasis in percutaneous nephrolithotripsy: A narrative review
Keywords:
nephrolithiasis, metaphylaxis, recurrence, PCNL, prevention, kidney stonesAbstract
Background and aim of the work: Urolithiasis (UC) remains a significant global public health concern, with prevalence ranging from 1.2% to 5.3% worldwide and a documented increase of 4.9% between 2017 and 2022. High recurrence rates following surgical treatment contribute substantially to long-term morbidity, healthcare costs, and reduced quality of life. Metaphylaxis has been proposed as a key strategy for preventing recurrent stone formation after percutaneous nephrolithotripsy (PCNL). The aim of this study was to assess the role of metaphylaxis in reducing UC recurrence and improving clinical outcomes after PCNL.
Research design and Methods: A narrative literature review was performed using PubMed, Embase, the Cochrane Library, Scopus, Web of Science, and Google Scholar. The search strategy included the terms “urolithiasis,” “nephrolithiasis,” “kidney stones,” “percutaneous nephrolithotripsy,” “recurrence,” and “metaphylaxis.” Meta-analyses, systematic reviews, original studies, and cross-sectional studies published between 2014 and 2024 were included. Non-peer-reviewed and non-evidence-based sources were excluded. In total, 50 peer-reviewed publications in English and Russian were analyzed.
Results: The reviewed evidence indicates that metaphylaxis significantly reduces the risk of UC recurrence following PCNL. Patients adhering to individualized dietary and pharmacological recommendations demonstrated a 30–50% reduction in recurrence rates within the first two years. Regular metabolic evaluation enabled early detection and correction of lithogenic risk factors, leading to improved patient-reported outcomes and reduced healthcare utilization.
Conclusions: Metaphylaxis represents a fundamental component of modern UC management after PCNL. An integrated approach combining dietary modification, targeted pharmacotherapy, and systematic metabolic monitoring effectively reduces recurrence rates and improves long-term outcomes. Broader implementation of metaphylaxis protocols in routine clinical practice is essential to mitigate the growing global burden of urolithiasis.
References
1. Scales CD Jr, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160–165. doi:10.1016/j.eururo.2012.03.052
2. Sorokin I, Mamoulakis C, Miyazawa K. Epidemiology of stone disease across the world. World J Urol. 2017;35(9):1301–1320. doi:10.1007/s00345-017-2008-6
3. R.A.F., Sh.M.S. Epidemiology of urolithiasis in the Turkestan region. Nauka i Zdravookhranenie. 2021;(3):[pages]. doi:10.34689/SH.2021.23.3.016
4. Alchinbaev MK. Urolithiasis in Kazakhstan: analysis of the situation and prospects. Urol Nephrol Kaz. 2016;2:9–21
5. Cheraghian B, Meysam A, Hashemi SJ. et al. Kidney stones and dietary intake in adults: a population-based study in southwest Iran. BMC Public Health. 2024;24(1):955. doi:10.1186/s12889-024-18393-1
6. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010;363(10):954–963. doi:10.1056/NEJMcp1001011
7. Gutbrod J, Keys McKay CC, Coe L. et al. Clinical effectiveness of calcium oxalate stone treatments. Am J Nephrol. 2022;53(10):761–766. doi:10.1159/000527940
8. Cohen R, Skup M, Ozbay AB. et al. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US. J Med Econ. 2015;18(6):447–456. doi:10.3111/13696998.2015.1021353
9. Raheem OA, Khandwala YS, Sur RL. Burden of urolithiasis: trends in prevalence, treatments, and costs. Eur Urol Focus. 2017;3(1):18–26. doi:10.1016/j.euf.2017.04.001
10. Ziemba JB, Matlaga BR. Epidemiology and economics of nephrolithiasis. Investig Clin Urol. 2017;58(5):299–306. doi:10.4111/icu.2017.58.5.299
11. Roberson D, Sperling C, Shah A. et al. Economic considerations in the management of nephrolithiasis. Curr Urol Rep. 2020;21(5):18. doi:10.1007/s11934-020-00971-6
12. Baowaidan F, Zugail AS, Lyoubi Y. Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: a retrospective single-centre study. Prog Urol. 2022;32(8–9):601–607. doi:10.1016/j.purol.2022.02.010
13. Cunha TDS, Rodriguez A, Heilberg IP. Influence of socioeconomic disparities, temperature and humidity in kidney stone composition. J Bras Nefrol. 2020;42(4):454–460. doi:10.1590/2175-8239-JBN-2019-0206
14. Zhao Z, Zhou J, Jing J. Clinical efficacy and short-term outcome of combining flexible cystoscopy with percutaneous nephrolithotomy for complex renal stone management. Am J Transl Res. 2024;16(4):1256–1265. doi:10.62347/OFET2671
15. Carbone A, Al Salhi Y, Tasca A. et al. Obesity and kidney stone disease: a systematic review. Minerva Urol Nefrol. 2018;70(4):393–400. doi:10.23736/S0393-2249.18.03113-2
16. Wang Y, Dong C, Jiang Q. Immune-inflammatory process in nephrolithiasis: a bibliometric analysis (2000–2023). Heliyon. 2024;10(16):e36604. doi:10.1016/j.heliyon.2024.e36604
17. Antonelli JA, Maalouf NM, Pearle MS. Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol. 2014;66(4):724–729. doi:10.1016/j.eururo.2014.06.036
18. Espinosa-Ortiz EJ, Gerlach R. Struvite stone formation by ureolytic biofilms. In: Lange D, Scotland K, editors. The role of bacteria in urology. Cham: Springer; 2019. p.61–70. doi:10.1007/978-3-030-17542-9_6
19. Prywer J, Olszynski M. Bacterially induced formation of infectious urinary stones: recent developments and future challenges. Curr Med Chem. 2017;24(3):292–311. doi:10.2174/0929867323666161028154545
20. Bauza JL, Pieras EC, Grases F. et al. Urinary tract infection’s etiopathogenic role in nephrolithiasis formation. Med Hypotheses. 2018;118:34–35. doi:10.1016/j.mehy.2018.06.002
21. da Cruz Machado J, Renteria JM, Medeiros do Nascimento M. Association between urinary lithiasis, other than struvite by crystallography and non-ureolytic bacteria. Urolithiasis. 2024;52(1):28. doi:10.1007/s00240-023-01525-4
22. Gefen AM, Zaritsky JJ. Review of childhood genetic nephrolithiasis and nephrocalcinosis. Front Genet. 2024;15:1381174. doi:10.3389/fgene.2024.1381174
23. De Stefano V, Castellani D, Somani BK. Suction in percutaneous nephrolithotripsy: evolution, development, and outcomes from experimental and clinical studies. Eur Urol Focus. 2024;10(1):154–168. doi:10.1016/j.euf.2023.06.010
24. Carella A, Leo S, Infante B. Nephrolithiasis in the elderly. Gerontol Geriatr. 2018;66(4):233–238
25. DiBianco JM, Ghani KR. Precision stone surgery: current status of miniaturized percutaneous nephrolithotomy. Curr Urol Rep. 2021;22(4):24. doi:10.1007/s11934-021-01042-0
26. Desai J, Shah HN. Mini percutaneous kidney stone removal: applicable technologies. Urol Clin North Am. 2022;49(1):161–173. doi:10.1016/j.ucl.2021.08.003
27. Ingimarsson JP, Krambeck AE, Pais VM Jr. Diagnosis and management of nephrolithiasis. Surg Clin North Am. 2016;96(3):517–532. doi:10.1016/j.suc.2016.02.008
28. Dhayat NA, Faller N, Bonny O. et al. Efficacy of standard and low dose hydrochlorothiazide in recurrence prevention of calcium nephrolithiasis (NOSTONE trial): protocol for a randomized double-blind placebo-controlled trial. BMC Nephrol. 2018;19(1):349. doi:10.1186/s12882-018-1144-6
29. Menditto VG, Milanese G, Muzzonigro G. Metaphylaxis of urolithiasis. Arch Ital Urol Androl. 2009;81(1):32–39
30. Medina Escobedo M, Sánchez Pozos K, Gutiérrez Solis AL. Recurrence of nephrolithiasis and surgical events are associated with chronic kidney disease in adult patients. Medicina (Kaunas). 2022;58(3):420. doi:10.3390/medicina58030420
31. Ma Y, Cheng C, Jian Z. Risk factors for nephrolithiasis formation: an umbrella review. Int J Surg. 2024;110(9):5733–5744. doi:10.1097/JS9.0000000000001719
32. Tiselius HG. Metabolic risk evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis. 2016;44(1):91–100. doi:10.1007/s00240-015-0840-y
33. Wang K, Ge J, Han W. Risk factors for kidney stone disease recurrence: a comprehensive meta analysis. BMC Urol. 2022;22(1):62. doi:10.1186/s12894-022-01017-4
34. Hsi RS, Stoller ML, Sreekanta A. The role of the 24 hour urine collection in the prevention of kidney stone recurrence. J Urol. 2017;197(4):1084–1089
35. Coe FL, Worcester EM, Evan AP. et al. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016;12(9):519–533. doi:10.1038/nrneph.2016.101
36. Curry JN, Yu ASL. Paracellular calcium transport in the proximal tubule and the formation of kidney stones. Am J Physiol Renal Physiol. 2019;316(5):F966–F969. doi:10.1152/ajprenal.00519.2018
37. Ferraro PM, Curhan GC, Gambaro G. Total, dietary, and supplemental vitamin C intake and risk of incident kidney stones. Am J Kidney Dis. 2016;67(3):400–407. doi:10.1053/j.ajkd.2015.09.005
38. Bolasco P, Reggiardo G. Influence of dietary heritage in a restricted geographic area and role of food additives on risk of recurrent kidney stone. Nutrients. 2024;16(17):2984. doi:10.3390/nu16172984
39. Bianco JM, Jarrett TW, Mufarrij P. et al. Metabolic syndrome and nephrolithiasis risk: should the medical management of nephrolithiasis include the treatment of metabolic syndrome? Rev Urol. 2015;17(3):117–128
40. Gökce Mİ, Güven S, Petkova K, et al. Patient compliance for metabolic evaluation and medical treatment (CoMET) in calcium oxalate stone patients: prospective study by EULIS eCORE study group. World J Urol. 2023;41(11):3135–3140. doi:10.1007/s00345-023-04610-w
41. Legay C, Haeusermann T, Pasquier J, et al. Differences in food consumption between kidney stone formers and nonformers in the Swiss Kidney Stone Cohort. J Ren Nutr. 2023;33(4):555–565. doi:10.1053/j.jrn.2023.04.007
42. Littlejohns TJ, Neal NL, Bradbury KE, et al. Fluid intake and dietary factors and the risk of incident kidney stones in UK Biobank. Eur Urol Focus. 2020;6(4):752–761. doi:10.1016/j.euf.2019.05.002
43. Ferraro PM, Taylor EN, Gambaro G. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol. 2013;190(6):2085–2091. doi:10.1016/j.juro.2013.06.046
44. Ticinesi A, Nouvenne A, Ferraro PM, et al. Dietary management of nephrolithiasis. Clin Cases Miner Bone Metab. 2017;14(2):173–179. doi:10.11138/ccmbm/2017.14.1.173
45. Sorensen MD, Eisner BH. Medical and dietary therapy for kidney stone prevention. World J Urol. 2016;35(9):1431–1439. doi:10.1007/s00345-016-1964-0
46. Ferraro PM, Taylor EN, Gambaro G. et al. Soda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol. 2013;8(8):1389–1395. doi:10.2215/CJN.11661112
47. Oliver K, Vilasi A, Maréchal A, et al. Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria. Sci Rep. 2016;6:34737. doi:10.1038/srep34737
48. Wu J, Yu H, Zhu Z, et al. Association between tea consumption and risk of kidney stones. Int Urol Nephrol. 2024;56(6):1835–1841. doi:10.1007/s11255-023-03918-1
49. Rice P, Archer M, Davis T, et al. Patient perception and barriers with fluid hydration: a prospective face to face interview and counselling from a university hospital stone clinic. Cent European J Urol. 2023;76(3):239–244. doi:10.5173/ceju.2023.105
50. Cheungpasitporn W, Rossetti S, Friend K, et al. Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta analysis. J Nephrol. 2016;29(2):211–219. doi:10.1007/s40620-015-0210-4
51. Neufingerl N, Eilander A. Nutrient intake and status in adults consuming plant based diets compared to meat eaters: a systematic review. Nutrients. 2021;14(1):29. doi:10.3390/nu14010029
52. Pan Y, Su J, Qian S, et al. Impact of habitual intake of glucosamine, fresh fruit, and tea on the risk of urolithiasis: a two sample Mendelian randomization study. Medicine (Baltimore). 2024;103(9):e37254. doi:10.1097/MD.0000000000037254
53. Wang Z, Zhang Y, Wei W, et al. Effect of dietary treatment and fluid intake on the prevention of recurrent calcium stones and changes in urine composition: a meta analysis and systematic review. PLoS One. 2021;16(4):e0250257. doi:10.1371/journal.pone.0250257
54. Jones P, Karim Sulaiman S, Gamage KN, et al. Do lifestyle factors including smoking, alcohol, and exercise impact your risk of developing kidney stone disease? J Endourol. 2021;35(1):1–7. doi:10.1089/end.2020.0378
55. Ye Z, Silverberg SJ, Sreekanta A, et al. The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta analysis of randomized controlled trials. J Bone Miner Res. 2022;37(11):2351–2372. doi:10.1002/jbmr.4685
56. Wang H, Fan J, Yu C, et al. Consumption of tea, alcohol, and fruits and risk of kidney stones: a prospective cohort study in 0.5 million Chinese adults. Nutrients. 2021;13(4):1119. doi:10.3390/nu13041119
57. Ferraro PM, Taylor EN, Gambaro G. et al. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol. 2017;198(4):858–863. doi:10.1016/j.juro.2017.03.124
58. Bao Y, Tu X, Wei Q. Water for preventing urinary stones. Cochrane Database Syst Rev. 2020;2(2):CD004292. doi:10.1002/14651858.CD004292.pub4
59. Cao P, Li Y, Zhang Z, et al. Metabolomics analysis reveals a protective effect of hydroxycitric acid on calcium oxalate induced kidney injury. Iran J Basic Med Sci. 2024;27(10):1243–1250. doi:10.22038/ijbms.2024.75089.16343
60. Wang Z, Zhang Y, Wei W, et al. Association between serum 25 hydroxyvitamin D concentrations and kidney stone risk: a cohort study in the UK Biobank. Int Urol Nephrol. 2024;56(11):3585–3594. doi:10.1007/s11255-024-04111-8
61. Barghouthy Y, Corrales M, Somani B, et al. The relationship between modern fad diets and kidney stone disease: a systematic review. Nutrients. 2021;13(12):4270. doi:10.3390/nu13124270
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Talgat A. Imzharov, Bazylbek S. Zhakiev, Marat N. Sarkulov, Valentin N. Pavlov, Alisher Mukash; Aliya M. Aitbayeva
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
